Miniaturized Dissolution Testing

Miniaturized Dissolution Testing is a specialized dissolution methodology within biorelevant dissolution testing that employs scaled-down apparatus and reduced sample volumes to enable high-throughput, resource-efficient evaluation of drug release profiles while maintaining physiological relevance.

38

Publications

1.1K

Citations

144

Authors

54

Institutions

Publications per year

2017–2026

8

Authors

144

  1. PM
    Piero M. Armenante

    New Jersey Institute of Technology, United States

    3 publications · 55 citations

    3

    h-index

  2. PM
    P. Mansky

    University of Massachusetts Amherst, United States

    2 publications · 121 citations

    2

    h-index

  3. GE
    Gary Eichenbaum

    Johnson & Johnson (United States), United States

    2 publications · 121 citations

    2

    h-index

  4. GB
    Gerard Bredael

    Merck & Co., Inc., Rahway, NJ, USA (United States), United States

    2 publications · 37 citations

    2

    h-index

  5. JA
    Jochem Alsenz

    Roche (Switzerland), Switzerland

    2 publications · 84 citations

    2

    h-index

1–5 of 144

Venues

  1. Journal of Pharmaceutical Sciences

    9 publications · 218 citations

    9

    h-index

  2. Dissolution Technologies

    8 publications · 170 citations

    8

    h-index

  3. International Journal of Pharmaceutics

    4 publications · 150 citations

    5

    h-index

  4. European Journal of Pharmaceutical Sciences

    5 publications · 179 citations

    5

    h-index

  5. 3

    h-index

1–5